| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $2.9M | -39.9% |
| SG&A Expense | $4.1M | -6.7% |
| Operating Income | -$7.0M | +23.9% |
| Pre-tax Income | -$6.2M | +26.3% |
| Income Tax | $800 | +0.0% |
| Net Income | -$6.2M | +26.3% |
| EPS (Basic) | -$1.93 | +34.1% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.0M | -81.5% |
| Accounts Receivable | $271K | -56.8% |
| Current Assets | $1.7M | -74.0% |
| Total Assets | $3.8M | -57.1% |
| Current Liabilities | $1.8M | +0.6% |
| Total Liabilities | $1.8M | -0.5% |
| Stockholders' Equity | $2.0M | -71.9% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | +26.3% |
| Financing Cash Flow | $592K | -87.7% |